NVCR - NovoCure Limited's (NVCR) Management on Q1 2022 Results - Earnings Call Transcript

NovoCure Limited (NVCR) Q1 2022 Earnings Conference Call April 28, 2022 8:00 AM ET Company Participants Ingrid Goldberg – Investor Relations Bill Doyle – Executive Chairman Ashley Cordova – Chief Financial Officer Pritesh Shah – Chief Commercial Officer Ely Benaim – Chief Medical Officer Conference Call Participants Cory Kasimov – J.P. Morgan Lei Huang – Wells Fargo Jason Bednar – Piper Sandler Greg Fraser – Truist Securities Jason Wittes – Loop Capital Kevin DeGeeter – Oppenheimer Presentation Operator Good day and welcome to NovoCure Q1 2022 Earnings Call. At this time all participants are in a listen-only mode. [Operator instructions] As a reminder, this call may be recorded. I'd like to turn the call over to Ingrid Goldberg. You may begin. Ingrid Goldberg Good morning everyone, and thank you for joining us to review NovoCure's first quarter 2022 performance. I'm joined on the phone by our Executive Chairman, Bill Doyle;

For further details see:

NovoCure Limited's (NVCR) Management on Q1 2022 Results - Earnings Call Transcript